Identification of High and Low Responders to Lipopolysaccharide in Normal Subjects: An Unbiased Approach to Identify Modulators of Innate Immunity
LPS stimulates a vigorous inflammatory response from circulating leukocytes that varies greatly from individual to individual. The goal of this study was to use an unbiased approach to identify differences in gene expression that may account for the high degree of interindividual variability in infl...
Saved in:
Published in | The Journal of immunology (1950) Vol. 175; no. 4; pp. 2570 - 2578 |
---|---|
Main Authors | , , , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
Am Assoc Immnol
15.08.2005
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | LPS stimulates a vigorous inflammatory response from circulating leukocytes that varies greatly from individual to individual. The goal of this study was to use an unbiased approach to identify differences in gene expression that may account for the high degree of interindividual variability in inflammatory responses to LPS in the normal human population. We measured LPS-induced cytokine production ex vivo in whole blood from 102 healthy human subjects and identified individuals who consistently showed either very high or very low responses to LPS (denoted lpshigh and lpslow, respectively). Comparison of gene expression profiles between the lpshigh and lpslow individuals revealed 80 genes that were differentially expressed in the presence of LPS and 21 genes that were differentially expressed in the absence of LPS (p < 0.005, ANOVA). Expression of a subset of these genes was confirmed using real-time RT-PCR. Functional relevance for one gene confirmed to be expressed at a higher level in lpshigh, adipophilin, was inferred when reduction in adipophilin mRNA by small interfering RNA in the human monocyte-like cell line THP-1 resulted in a modest but significant reduction in LPS-induced MCP-1 mRNA expression. These data illustrate a novel approach to the identification of factors that determine interindividual variability in innate immune inflammatory responses and identify adipophilin as a novel potential regulator of LPS-induced MCP-1 production in human monocytes. |
---|---|
AbstractList | LPS stimulates a vigorous inflammatory response from circulating leukocytes that varies greatly from individual to individual. The goal of this study was to use an unbiased approach to identify differences in gene expression that may account for the high degree of interindividual variability in inflammatory responses to LPS in the normal human population. We measured LPS-induced cytokine production ex vivo in whole blood from 102 healthy human subjects and identified individuals who consistently showed either very high or very low responses to LPS (denoted lpshigh and lpslow, respectively). Comparison of gene expression profiles between the lpshigh and lpslow individuals revealed 80 genes that were differentially expressed in the presence of LPS and 21 genes that were differentially expressed in the absence of LPS (p < 0.005, ANOVA). Expression of a subset of these genes was confirmed using real-time RT-PCR. Functional relevance for one gene confirmed to be expressed at a higher level in lpshigh, adipophilin, was inferred when reduction in adipophilin mRNA by small interfering RNA in the human monocyte-like cell line THP-1 resulted in a modest but significant reduction in LPS-induced MCP-1 mRNA expression. These data illustrate a novel approach to the identification of factors that determine interindividual variability in innate immune inflammatory responses and identify adipophilin as a novel potential regulator of LPS-induced MCP-1 production in human monocytes. LPS stimulates a vigorous inflammatory response from circulating leukocytes that varies greatly from individual to individual. The goal of this study was to use an unbiased approach to identify differences in gene expression that may account for the high degree of interindividual variability in inflammatory responses to LPS in the normal human population. We measured LPS-induced cytokine production ex vivo in whole blood from 102 healthy human subjects and identified individuals who consistently showed either very high or very low responses to LPS (denoted lps sub(high) and lps sub(low), respectively). Comparison of gene expression profiles between the lps sub(high) and lps sub(low) individuals revealed 80 genes that were differentially expressed in the presence of LPS and 21 genes that were differentially expressed in the absence of LPS (p < 0.005, ANOVA). Expression of a subset of these genes was confirmed using real-time RT-PCR. Functional relevance for one gene confirmed to be expressed at a higher level in lps sub(high), adipophilin, was inferred when reduction in adipophilin mRNA by small interfering RNA in the human monocyte-like cell line THP-1 resulted in a modest but significant reduction in LPS-induced MCP-1 mRNA expression. These data illustrate a novel approach to the identification of factors that determine interindividual variability in innate immune inflammatory responses and identify adipophilin as a novel potential regulator of LPS-induced MCP-1 production in human monocytes. LPS stimulates a vigorous inflammatory response from circulating leukocytes that varies greatly from individual to individual. The goal of this study was to use an unbiased approach to identify differences in gene expression that may account for the high degree of interindividual variability in inflammatory responses to LPS in the normal human population. We measured LPS-induced cytokine production ex vivo in whole blood from 102 healthy human subjects and identified individuals who consistently showed either very high or very low responses to LPS (denoted lps(high) and lps(low), respectively). Comparison of gene expression profiles between the lps(high) and lps(low) individuals revealed 80 genes that were differentially expressed in the presence of LPS and 21 genes that were differentially expressed in the absence of LPS (p < 0.005, ANOVA). Expression of a subset of these genes was confirmed using real-time RT-PCR. Functional relevance for one gene confirmed to be expressed at a higher level in lps(high), adipophilin, was inferred when reduction in adipophilin mRNA by small interfering RNA in the human monocyte-like cell line THP-1 resulted in a modest but significant reduction in LPS-induced MCP-1 mRNA expression. These data illustrate a novel approach to the identification of factors that determine interindividual variability in innate immune inflammatory responses and identify adipophilin as a novel potential regulator of LPS-induced MCP-1 production in human monocytes. LPS stimulates a vigorous inflammatory response from circulating leukocytes that varies greatly from individual to individual. The goal of this study was to use an unbiased approach to identify differences in gene expression that may account for the high degree of interindividual variability in inflammatory responses to LPS in the normal human population. We measured LPS-induced cytokine production ex vivo in whole blood from 102 healthy human subjects and identified individuals who consistently showed either very high or very low responses to LPS (denoted lps(high) and lps(low), respectively). Comparison of gene expression profiles between the lps(high) and lps(low) individuals revealed 80 genes that were differentially expressed in the presence of LPS and 21 genes that were differentially expressed in the absence of LPS (p < 0.005, ANOVA). Expression of a subset of these genes was confirmed using real-time RT-PCR. Functional relevance for one gene confirmed to be expressed at a higher level in lps(high), adipophilin, was inferred when reduction in adipophilin mRNA by small interfering RNA in the human monocyte-like cell line THP-1 resulted in a modest but significant reduction in LPS-induced MCP-1 mRNA expression. These data illustrate a novel approach to the identification of factors that determine interindividual variability in innate immune inflammatory responses and identify adipophilin as a novel potential regulator of LPS-induced MCP-1 production in human monocytes.LPS stimulates a vigorous inflammatory response from circulating leukocytes that varies greatly from individual to individual. The goal of this study was to use an unbiased approach to identify differences in gene expression that may account for the high degree of interindividual variability in inflammatory responses to LPS in the normal human population. We measured LPS-induced cytokine production ex vivo in whole blood from 102 healthy human subjects and identified individuals who consistently showed either very high or very low responses to LPS (denoted lps(high) and lps(low), respectively). Comparison of gene expression profiles between the lps(high) and lps(low) individuals revealed 80 genes that were differentially expressed in the presence of LPS and 21 genes that were differentially expressed in the absence of LPS (p < 0.005, ANOVA). Expression of a subset of these genes was confirmed using real-time RT-PCR. Functional relevance for one gene confirmed to be expressed at a higher level in lps(high), adipophilin, was inferred when reduction in adipophilin mRNA by small interfering RNA in the human monocyte-like cell line THP-1 resulted in a modest but significant reduction in LPS-induced MCP-1 mRNA expression. These data illustrate a novel approach to the identification of factors that determine interindividual variability in innate immune inflammatory responses and identify adipophilin as a novel potential regulator of LPS-induced MCP-1 production in human monocytes. |
Author | Park, William Y Ruzinski, John Strout, Jeanna Martin, Thomas R Radella, Frank Wurfel, Mark M Sandstrom, Andrew Bumgarner, Roger E |
Author_xml | – sequence: 1 fullname: Wurfel, Mark M – sequence: 2 fullname: Park, William Y – sequence: 3 fullname: Radella, Frank – sequence: 4 fullname: Ruzinski, John – sequence: 5 fullname: Sandstrom, Andrew – sequence: 6 fullname: Strout, Jeanna – sequence: 7 fullname: Bumgarner, Roger E – sequence: 8 fullname: Martin, Thomas R |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/16081831$$D View this record in MEDLINE/PubMed |
BookMark | eNqFkc1u1DAUhS1URKctT4CEvIJVBjt2nITdqKLtSANI0K4tj38YjxI72I6ieY0-cR1mihALWF3J-s651-dcgDPnnQbgDUZLimj7YW_7fnS-W-K6WtJlWdXoBVjgqkIFY4idgQVCZVngmtXn4CLGPUKIoZK-AueYoQY3BC_A41ppl6yxUiTrHfQG3tkfOyicghs_wW86Dt4pHSJMHm7s4AffHaKQcieCVRpaB7_40IsOfh-3ey1T_AhXDj64rRVRK7gahuCF3M3y064D_OzV2Inks2teuHZOJA3X83dsOlyBl0Z0Ub8-zUvwcPPp_vqu2Hy9XV-vNoWkGKeiVUwpgZRBLA_dSlMjQxBr2poaIhvJqNAMaUM0IVW9JSQ_NG2pTFWKRpXkErw7-uYDf446Jt7bKHXXCaf9GDlrKG1ZVf8XzPm3VYtoBt-ewHHba8WHYHsRDvw57gy0R0AGH2PQhkubfgWfgrAdx4jP1fLnamdrTvlcbdaSv7S_7f-pen9U7XKrkw2ax9xVlw_EfJqmP8gnHgC6fQ |
CitedBy_id | crossref_primary_10_2310_JIM_0b013e3181891560 crossref_primary_10_1016_j_physbeh_2016_11_012 crossref_primary_10_1042_CS20070214 crossref_primary_10_1371_journal_pone_0081617 crossref_primary_10_1186_s12865_022_00534_z crossref_primary_10_1186_1465_9921_8_64 crossref_primary_10_1016_j_toxrep_2017_10_004 crossref_primary_10_1111_anae_13868 crossref_primary_10_1016_j_coi_2014_06_002 crossref_primary_10_1177_1099800416629209 crossref_primary_10_1016_j_tem_2024_04_004 crossref_primary_10_1007_s11010_009_0299_7 crossref_primary_10_1371_journal_pone_0117261 crossref_primary_10_1155_2014_293925 crossref_primary_10_3168_jds_2011_4288 crossref_primary_10_1002_JLB_4MA0320_544RR crossref_primary_10_1016_j_vetimm_2010_10_006 crossref_primary_10_1016_j_jprot_2024_105232 crossref_primary_10_3349_ymj_2016_57_1_111 crossref_primary_10_1111_j_1365_2249_2006_03074_x crossref_primary_10_1177_01926233231190382 crossref_primary_10_1165_rcmb_2010_0342OC crossref_primary_10_1164_rccm_201307_1208ED crossref_primary_10_1099_vir_0_038414_0 crossref_primary_10_1016_j_rvsc_2012_09_019 crossref_primary_10_1016_j_cell_2012_08_043 crossref_primary_10_3389_fimmu_2020_569331 crossref_primary_10_2217_imt_2019_0096 crossref_primary_10_3390_cells10123279 crossref_primary_10_1007_s00204_008_0290_1 crossref_primary_10_1016_j_molmed_2005_11_002 crossref_primary_10_1371_journal_pone_0013759 crossref_primary_10_1371_journal_pone_0008583 crossref_primary_10_1016_j_jim_2013_08_006 crossref_primary_10_1186_1471_2288_12_112 crossref_primary_10_4049_jimmunol_177_11_8086 crossref_primary_10_1016_j_jnutbio_2011_03_004 crossref_primary_10_1016_j_ajog_2009_05_012 crossref_primary_10_1097_SHK_0000000000001915 crossref_primary_10_1369_00221554211054447 crossref_primary_10_1515_CCLM_2007_035 crossref_primary_10_1002_eji_200737034 crossref_primary_10_1097_01_CCM_0000220051_19432_05 crossref_primary_10_1016_j_taap_2008_01_033 crossref_primary_10_2310_JIM_0b013e31829cbd14 crossref_primary_10_4049_jimmunol_1103319 crossref_primary_10_1016_j_jpurol_2017_05_025 crossref_primary_10_1152_ajplung_00139_2007 crossref_primary_10_1016_j_ccc_2011_05_013 crossref_primary_10_1172_JCI86802 crossref_primary_10_1371_journal_pone_0028768 crossref_primary_10_1088_0022_3727_47_22_224015 crossref_primary_10_1007_s00011_022_01543_9 crossref_primary_10_1016_j_heares_2006_05_012 crossref_primary_10_1002_ppap_201200087 crossref_primary_10_1086_674439 crossref_primary_10_4049_jimmunol_0903463 crossref_primary_10_1089_sur_2009_018 crossref_primary_10_1111_j_1365_2567_2008_02915_x crossref_primary_10_3389_fimmu_2020_577823 crossref_primary_10_3389_fimmu_2022_871780 crossref_primary_10_1016_j_mtbio_2020_100080 crossref_primary_10_1128_MMBR_05015_11 crossref_primary_10_1073_pnas_0706097104 crossref_primary_10_1080_15321819_2015_1047516 crossref_primary_10_1371_journal_pone_0188881 crossref_primary_10_1016_S2213_2600_21_00157_0 crossref_primary_10_1038_mi_2012_139 crossref_primary_10_1111_j_1365_2567_2008_02907_x crossref_primary_10_1158_1078_0432_CCR_16_2199 crossref_primary_10_1016_j_celrep_2020_108590 crossref_primary_10_1016_j_autneu_2019_102580 crossref_primary_10_1177_0192623309343778 crossref_primary_10_1080_13547500601160536 crossref_primary_10_1016_j_bbih_2020_100080 crossref_primary_10_1164_rccm_200803_462OC crossref_primary_10_1007_s12026_015_8640_6 crossref_primary_10_1086_590440 crossref_primary_10_1097_CCM_0b013e31819c14fa crossref_primary_10_1016_j_suc_2008_09_004 crossref_primary_10_1016_j_bbi_2016_10_003 crossref_primary_10_1038_s41398_021_01359_x crossref_primary_10_1002_art_27325 crossref_primary_10_1002_dta_1973 crossref_primary_10_1097_CCM_0b013e31819d2daa crossref_primary_10_1097_01_shk_0000232589_39001_4d crossref_primary_10_1186_gb_2010_11_1_r3 crossref_primary_10_1038_s41390_022_02153_1 crossref_primary_10_1371_journal_pone_0135527 crossref_primary_10_1002_ptr_4678 crossref_primary_10_1371_journal_pone_0097702 crossref_primary_10_1186_s13567_018_0616_9 crossref_primary_10_3168_jds_2008_1954 crossref_primary_10_1038_gene_2012_53 |
Cites_doi | 10.1074/jbc.M100099200 10.1038/sj.gene.6363979 10.1006/cyto.1998.0471 10.1056/NEJM200103083441001 10.1073/pnas.022649799 10.1378/chest.126.1.95 10.1084/jem.20030701 10.1016/S0022-1759(98)00108-2 10.5551/jat.11.88 10.4049/jimmunol.172.8.4977 10.1126/science.1081902 10.1189/jlb.0203082 10.1002/eji.1830191222 10.1152/jappl.1991.71.5.1979 10.1016/j.jpeds.2003.10.034 10.1161/01.ATV.0000115638.27381.97 10.1126/science.3895437 10.1084/jem.172.1.77 10.1097/00003246-200205000-00003 10.4049/jimmunol.170.7.3451 10.1016/S0006-2952(98)00105-1 10.1001/archinte.162.9.1028 10.1006/brbi.1999.0570 10.1182/blood.V99.10.3524 10.1038/nature02623 10.1006/scdb.1998.0275 10.1002/jlb.56.1.1 10.1084/jem.20031220 10.1016/0090-1229(88)90130-4 10.1097/00003246-200103000-00015 10.1182/blood-2002-10-3232 10.1016/S1388-1981(01)00121-4 10.1086/379044 10.1086/375744 10.4049/jimmunol.169.1.10 10.1111/j.1432-1033.1992.tb16999.x 10.1006/cyto.1996.0155 10.1073/pnas.89.17.7856 10.1016/S0022-2275(20)34939-7 10.1038/330662a0 10.1073/pnas.231625398 10.1038/3327 10.1126/science.1099870 10.1016/S0014-5793(99)01521-5 10.1001/jama.263.7.937 10.1182/blood.V89.11.4182 10.1111/j.1432-1033.1991.tb16139.x 10.1073/pnas.1031605100 10.1101/gr.6.10.995 10.1016/S0092-8674(00)00015-5 10.1038/sj.onc.1201206 10.1097/00003246-200103000-00006 10.1086/344893 |
ContentType | Journal Article |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7T5 H94 7X8 |
DOI | 10.4049/jimmunol.175.4.2570 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed Immunology Abstracts AIDS and Cancer Research Abstracts MEDLINE - Academic |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) AIDS and Cancer Research Abstracts Immunology Abstracts MEDLINE - Academic |
DatabaseTitleList | CrossRef AIDS and Cancer Research Abstracts MEDLINE MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Biology |
EISSN | 1550-6606 |
EndPage | 2578 |
ExternalDocumentID | 16081831 10_4049_jimmunol_175_4_2570 www175_4_2570 |
Genre | Research Support, U.S. Gov't, Non-P.H.S Research Support, U.S. Gov't, P.H.S Comparative Study Journal Article Research Support, N.I.H., Extramural |
GrantInformation_xml | – fundername: PHS HHS grantid: K23 62-9063 – fundername: NHLBI NIH HHS grantid: 1 P50 HL073996-01 – fundername: NIAID NIH HHS grantid: U54 AI057141 |
GroupedDBID | - 08R 2WC 34G 39C 3O- 53G 55 5GY 5RE 5VS 79B 85S 8RP AALRV AARDX ABEFU ABFLS ABOCM ABPPZ ABPTK ACGFS ACIWK ACNCT ACPRK ADACO ADBBV ADKFC AENEX AETEA AFFNX AFRAH AJYGW ALMA_UNASSIGNED_HOLDINGS BAWUL D0L DIK DU5 E3Z EBS EJD F5P FH7 FRP G8K GJ GX1 H13 IH2 J5H K-O K78 KQ8 L7B MVM MYA NEJ O0- OK1 P0W P2P PQEST PQQKQ R.V RHF RHI RZQ SJN TWZ VH1 WH7 WOQ X X7M XJT ZA5 ZE2 ZGI --- -~X .55 .GJ 0R~ 18M 5WD AAYXX ABCQX ABDFA ABDPE ABEJV ABGNP ABJNI ABXVV ACGFO ADIPN ADNWM ADXHL AFHIN AFOSN AGORE AHMMS AHWXS AI. AIZAD ARBBW BCRHZ BTFSW CITATION OCZFY OWPYF ROX TR2 W8F XSW XTH YHG CGR CUY CVF ECM EIF NPM VXZ YIN 7T5 H94 7X8 |
ID | FETCH-LOGICAL-c411t-9d6dda0df06da0e9cf70f3068974f3c8c64ae60ef3e3357b3364a892df52a8d23 |
ISSN | 0022-1767 |
IngestDate | Fri Jul 11 06:48:36 EDT 2025 Tue Aug 05 10:50:39 EDT 2025 Wed Feb 19 02:35:24 EST 2025 Tue Jul 01 01:03:24 EDT 2025 Thu Apr 24 23:09:54 EDT 2025 Tue Nov 10 19:50:36 EST 2020 |
IsDoiOpenAccess | false |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 4 |
Language | English |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c411t-9d6dda0df06da0e9cf70f3068974f3c8c64ae60ef3e3357b3364a892df52a8d23 |
Notes | ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-1 content type line 23 |
OpenAccessLink | https://journals.aai.org/jimmunol/article-pdf/175/4/2570/1207102/2570.pdf |
PMID | 16081831 |
PQID | 17595904 |
PQPubID | 23462 |
PageCount | 9 |
ParticipantIDs | proquest_miscellaneous_68449657 proquest_miscellaneous_17595904 pubmed_primary_16081831 crossref_citationtrail_10_4049_jimmunol_175_4_2570 crossref_primary_10_4049_jimmunol_175_4_2570 highwire_smallpub1_www175_4_2570 |
ProviderPackageCode | RHF RHI CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2005-08-15 |
PublicationDateYYYYMMDD | 2005-08-15 |
PublicationDate_xml | – month: 08 year: 2005 text: 2005-08-15 day: 15 |
PublicationDecade | 2000 |
PublicationPlace | United States |
PublicationPlace_xml | – name: United States |
PublicationTitle | The Journal of immunology (1950) |
PublicationTitleAlternate | J Immunol |
PublicationYear | 2005 |
Publisher | Am Assoc Immnol |
Publisher_xml | – name: Am Assoc Immnol |
References | 2023010121130924400_R8 2023010121130924400_R37 2023010121130924400_R9 2023010121130924400_R38 2023010121130924400_R6 2023010121130924400_R35 2023010121130924400_R7 2023010121130924400_R36 2023010121130924400_R4 2023010121130924400_R33 2023010121130924400_R5 2023010121130924400_R34 2023010121130924400_R2 2023010121130924400_R31 2023010121130924400_R3 2023010121130924400_R32 2023010121130924400_R1 2023010121130924400_R30 2023010121130924400_R28 2023010121130924400_R29 2023010121130924400_R48 2023010121130924400_R49 2023010121130924400_R46 2023010121130924400_R47 2023010121130924400_R44 2023010121130924400_R45 2023010121130924400_R42 2023010121130924400_R43 2023010121130924400_R40 2023010121130924400_R41 2023010121130924400_R39 2023010121130924400_R15 2023010121130924400_R16 2023010121130924400_R13 2023010121130924400_R14 2023010121130924400_R11 2023010121130924400_R12 2023010121130924400_R53 2023010121130924400_R10 2023010121130924400_R54 2023010121130924400_R51 2023010121130924400_R52 2023010121130924400_R50 2023010121130924400_R26 2023010121130924400_R27 2023010121130924400_R24 2023010121130924400_R25 2023010121130924400_R22 2023010121130924400_R23 2023010121130924400_R20 2023010121130924400_R21 2023010121130924400_R19 2023010121130924400_R17 2023010121130924400_R18 J Immunol. 2006 Feb 15;176(4):2669 |
References_xml | – ident: 2023010121130924400_R53 doi: 10.1074/jbc.M100099200 – ident: 2023010121130924400_R31 doi: 10.1038/sj.gene.6363979 – ident: 2023010121130924400_R16 doi: 10.1006/cyto.1998.0471 – ident: 2023010121130924400_R2 doi: 10.1056/NEJM200103083441001 – ident: 2023010121130924400_R22 doi: 10.1073/pnas.022649799 – ident: 2023010121130924400_R30 doi: 10.1378/chest.126.1.95 – ident: 2023010121130924400_R37 doi: 10.1084/jem.20030701 – ident: 2023010121130924400_R15 doi: 10.1016/S0022-1759(98)00108-2 – ident: 2023010121130924400_R52 doi: 10.5551/jat.11.88 – ident: 2023010121130924400_R23 doi: 10.4049/jimmunol.172.8.4977 – ident: 2023010121130924400_R36 doi: 10.1126/science.1081902 – ident: 2023010121130924400_R5 doi: 10.1189/jlb.0203082 – ident: 2023010121130924400_R18 doi: 10.1002/eji.1830191222 – ident: 2023010121130924400_R8 doi: 10.1152/jappl.1991.71.5.1979 – ident: 2023010121130924400_R38 doi: 10.1016/j.jpeds.2003.10.034 – ident: 2023010121130924400_R26 doi: 10.1161/01.ATV.0000115638.27381.97 – ident: 2023010121130924400_R6 doi: 10.1126/science.3895437 – ident: 2023010121130924400_R10 doi: 10.1084/jem.172.1.77 – ident: 2023010121130924400_R39 doi: 10.1097/00003246-200205000-00003 – ident: 2023010121130924400_R33 doi: 10.4049/jimmunol.170.7.3451 – ident: 2023010121130924400_R25 doi: 10.1016/S0006-2952(98)00105-1 – ident: 2023010121130924400_R42 doi: 10.1001/archinte.162.9.1028 – ident: 2023010121130924400_R9 doi: 10.1006/brbi.1999.0570 – ident: 2023010121130924400_R32 doi: 10.1182/blood.V99.10.3524 – ident: 2023010121130924400_R4 doi: 10.1038/nature02623 – ident: 2023010121130924400_R50 doi: 10.1006/scdb.1998.0275 – ident: 2023010121130924400_R14 doi: 10.1002/jlb.56.1.1 – ident: 2023010121130924400_R35 doi: 10.1084/jem.20031220 – ident: 2023010121130924400_R19 doi: 10.1016/0090-1229(88)90130-4 – ident: 2023010121130924400_R40 doi: 10.1097/00003246-200103000-00015 – ident: 2023010121130924400_R24 doi: 10.1182/blood-2002-10-3232 – ident: 2023010121130924400_R27 doi: 10.1016/S1388-1981(01)00121-4 – ident: 2023010121130924400_R41 doi: 10.1086/379044 – ident: 2023010121130924400_R29 doi: 10.1086/375744 – ident: 2023010121130924400_R28 doi: 10.4049/jimmunol.169.1.10 – ident: 2023010121130924400_R46 doi: 10.1111/j.1432-1033.1992.tb16999.x – ident: 2023010121130924400_R20 doi: 10.1006/cyto.1996.0155 – ident: 2023010121130924400_R48 doi: 10.1073/pnas.89.17.7856 – ident: 2023010121130924400_R17 – ident: 2023010121130924400_R51 doi: 10.1016/S0022-2275(20)34939-7 – ident: 2023010121130924400_R7 doi: 10.1038/330662a0 – ident: 2023010121130924400_R21 doi: 10.1073/pnas.231625398 – ident: 2023010121130924400_R12 doi: 10.1038/3327 – ident: 2023010121130924400_R44 doi: 10.1126/science.1099870 – ident: 2023010121130924400_R49 doi: 10.1016/S0014-5793(99)01521-5 – ident: 2023010121130924400_R1 doi: 10.1001/jama.263.7.937 – ident: 2023010121130924400_R54 doi: 10.1182/blood.V89.11.4182 – ident: 2023010121130924400_R45 doi: 10.1111/j.1432-1033.1991.tb16139.x – ident: 2023010121130924400_R34 doi: 10.1073/pnas.1031605100 – ident: 2023010121130924400_R13 doi: 10.1101/gr.6.10.995 – ident: 2023010121130924400_R11 doi: 10.1016/S0092-8674(00)00015-5 – ident: 2023010121130924400_R47 doi: 10.1038/sj.onc.1201206 – ident: 2023010121130924400_R3 doi: 10.1097/00003246-200103000-00006 – ident: 2023010121130924400_R43 doi: 10.1086/344893 – reference: - J Immunol. 2006 Feb 15;176(4):2669 |
SSID | ssj0006024 |
Score | 2.1749167 |
Snippet | LPS stimulates a vigorous inflammatory response from circulating leukocytes that varies greatly from individual to individual. The goal of this study was to... |
SourceID | proquest pubmed crossref highwire |
SourceType | Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 2570 |
SubjectTerms | Adolescent Adult Aged Analysis of Variance Cell Line, Tumor Chemokine CCL2 - biosynthesis Chemokine CCL2 - genetics Cytokines - biosynthesis Cytokines - blood Cytokines - genetics Cytokines - physiology Dose-Response Relationship, Immunologic Female Gene Expression Profiling - methods Gene Expression Profiling - standards Gene Expression Profiling - statistics & numerical data Humans Immunity, Innate - genetics Immunophenotyping Inflammation Mediators - blood Inflammation Mediators - metabolism Inflammation Mediators - physiology Lipopolysaccharides - pharmacology Male Membrane Proteins - biosynthesis Membrane Proteins - physiology Middle Aged Perilipin-2 RNA, Messenger - biosynthesis |
Title | Identification of High and Low Responders to Lipopolysaccharide in Normal Subjects: An Unbiased Approach to Identify Modulators of Innate Immunity |
URI | http://www.jimmunol.org/cgi/content/abstract/175/4/2570 https://www.ncbi.nlm.nih.gov/pubmed/16081831 https://www.proquest.com/docview/17595904 https://www.proquest.com/docview/68449657 |
Volume | 175 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1bb9MwFLbKEIgXBONWrn6Ap9GS2M6Ntwk2bdAVNLVib1Yax6KoSqc1VdX9DH4BP5VzYjtJRcftoWkUOXaa76t9zvG5EPJSpBHjaZb1EpXEoKCIoJdo7fVSnymfMV-pGAOFT4bh0Vh8OAvOOp0fLa-lZTnpZ5db40r-B1W4BrhilOw_IFt3ChfgHPCFIyAMx7_C2ETZamt2q2zyoGtX-wGDOdr90f8VPZVRwhxMz7EgwnoB7-wraMiqShcyRJl1hvMHGmQW1k44LiZTWN4UCql1yJUdbY3107DoF5bpqQJRCpBX946rQJNyY5e4iTszqSmwicn59KraWfNadogvywttPAYwfKgx0n62ztzWMLRXi96nmOByljrpu444Ol1e1tW4a0djZ9cI0FBrIjtbcQZ-ZIp11HN1FLRIKdozb2AKkNhVHGeibSsEsBETrH6zv7gPHfZFv7m5nY97-EkejgcDOTo4G10j1xkoIlgj4_3xx3qtDz0mXD56fFaT1woHebNliE3Zx-Wjvlq3qWSc0R1y20JF9w3T7pJOXuySG6Zc6XqX3Dyxjhj3yPdN6tG5pkg9CtSjQD3aUI-Wc_or9ei0oIZ61FHvLd0vqCMedcTD2x3xaEM8HNAQjzri3Sfjw4PRu6OeLe_Ry4TvlzA7hEqlntJeCF95kunI06DBxqDiap7FWSjSPPRyzXPOg2jCOVyIE6Z0wNJYMf6A7BTzIn9EKEhcWngcPr4S-USlPAtR12GeyMJA5V3C3IuXmc19jyVYZhJ0YERLOrQkoCWFRLS65HV907lJ_fL75tQhKhfw-maApC9Xq1W7yQuHtIRZHLfm0iKfLxfYTRIknri6RRgLLO0QdclDQ5HmmUJMS8n9x3_s_Qm51fzTnpKd8mKZPwOZupw8r2j9E1l70rk |
linkProvider | Flying Publisher |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Identification+of+High+and+Low+Responders+to+Lipopolysaccharide+in+Normal+Subjects%3A+An+Unbiased+Approach+to+Identify+Modulators+of+Innate+Immunity&rft.jtitle=The+Journal+of+immunology+%281950%29&rft.au=Wurfel%2C+Mark+M&rft.au=Park%2C+William+Y&rft.au=Radella%2C+Frank&rft.au=Ruzinski%2C+John&rft.date=2005-08-15&rft.issn=0022-1767&rft.volume=175&rft.issue=4&rft.spage=2570&rft.epage=2578&rft_id=info:doi/10.4049%2Fjimmunol.175.4.2570&rft.externalDBID=NO_FULL_TEXT |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0022-1767&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0022-1767&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0022-1767&client=summon |